Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is -142.32x as of the fiscal period ended Monday, June 30, 2025.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2025 (2025-06-30): -142.32x.
INTEREST COVERAGE RATIO
-142.32x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.12x
median of 422 covered companies
CURRENT VS SECTOR MEDIAN
-2682.37%
vs the sector median at left
Incannex Healthcare Limited
Market Cap
$38.35M
Interest Coverage Ratio
-142.32x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$39.33M
Interest Coverage Ratio
-0.13x
TTM Avg
0.53x
3Y Avg
0.64x
5Y Avg
0.43x
Market Cap
$36.99M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$39.90M
Interest Coverage Ratio
1146.00x
TTM Avg
576.00x
3Y Avg
576.00x
5Y Avg
576.00x
Market Cap
$36.31M
Interest Coverage Ratio
-87.92x
TTM Avg
13.24x
3Y Avg
16.68x
5Y Avg
16.68x
Market Cap
$36.99M
Interest Coverage Ratio
-33.29x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$40.28M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$35.52M
Interest Coverage Ratio
47.58x
TTM Avg
47.58x
3Y Avg
47.58x
5Y Avg
47.58x
Market Cap
$35.15M
Interest Coverage Ratio
-735.69x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Incannex Healthcare Limited (IXHL) | $38.35M | -142.32x | N/A | N/A | N/A |
| Harvard Bioscience, Inc. (HBIO)vs › | $39.33M | -0.13x | 0.53x | 0.64x | 0.43x |
| Edesa Biotech, Inc. (EDSA)vs › | $36.99M | N/A | N/A | N/A | N/A |
| Nephros, Inc. (NEPH)vs › | $39.90M | 1146.00x | 576.00x | 576.00x | 576.00x |
| DocGo Inc. (DCGO)vs › | $36.31M | -87.92x | 13.24x | 16.68x | 16.68x |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.99M | -33.29x | N/A | N/A | N/A |
| Metagenomi, Inc. Common Stock (MGX)vs › | $40.28M | N/A | N/A | N/A | N/A |
| Elutia Inc (ELUT)vs › | $35.52M | 47.58x | 47.58x | 47.58x | 47.58x |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.15M | -735.69x | N/A | N/A | N/A |
| Accuray Incorporated (ARAY)vs › | $34.54M | -0.75x | 0.33x | 0.47x | 0.65x |
Interest Coverage
-142.3x
Debt/Equity
0.00
Current Ratio
48.81
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-06-30 | -142.32x |
| 2019-06-30 | -241.96x |
| 2018-12-31 | -16.77x |
| 2018-06-30 | -487.48x |
| 2017-12-31 | -379.44x |
| 2017-06-30 | -100.27x |
| 2016-12-31 | -40.59x |
